Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 24 Nov 2017 | Vytenis Andriukaitis Commissioner | Pharmaceutical policy | — |
| 24 Nov 2017 | Vytenis Andriukaitis Commissioner | Pharmaceutical policy | SRC |
Mission & Goals
PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.
EU Legislative Interests
European Medicines Agency activities Industrial policy Research policy Public funding for research
Communication Activities
Projects communication financed by Horizon Europe Drug Approval procedures
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Farmaindustria - https://www.farmaindustria.es/web/ The Cancer Drug Development Forum (CDDF) - https://cddf.org/
Organisation Members
https://pharmamar.com/es/nosotros/socios/ https://pharmamar.com/es/nosotros/nuestra-ciencia/proyectos-cofinanciados/ https://sylentis.com/es/